Cargando…
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
A mutation in the isocitrate dehydrogenase 1 (IDH1) gene is the most common mutation in diffuse lower-grade gliomas (LGGs), and it is significantly related to the prognosis of LGGs. We aimed to explore the influence of the IDH1 mutation on the immune microenvironment and develop an IDH1-associated i...
Autores principales: | Deng, Xiangyang, Lin, Dongdong, Chen, Bo, Zhang, Xiaojia, Xu, Xingxing, Yang, Zelin, Shen, Xuchao, Yang, Liang, Lu, Xiangqi, Sheng, Hansong, Yin, Bo, Zhang, Nu, Lin, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883600/ https://www.ncbi.nlm.nih.gov/pubmed/31824866 http://dx.doi.org/10.3389/fonc.2019.01310 |
Ejemplares similares
-
IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019) -
Personalizing age‐specific survival prediction and risk stratification in intracranial grade II/III ependymoma
por: Deng, Xiangyang, et al.
Publicado: (2019) -
Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma
por: Deng, Xiangyang, et al.
Publicado: (2020) -
The role of postoperative radiotherapy in pediatric patients with grade II intracranial ependymomas: a population-based, propensity score-matched study
por: Deng, Xiangyang, et al.
Publicado: (2018) -
Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade Glioma
por: Kang, Houyi, et al.
Publicado: (2020)